P2RY12 and acute coronary syndrome: Ticagrelor takes effect quickly after entering patients with acute coronary syndrome, does not need liver metabolic activation, can quickly bind to P2Y12 adenosine diphosphate receptor, plays the role of antiplatelet excessive aggregation, and has a good protective effect on vasodilation and myocardial tissue.